The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026.
If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance on
Friday, September 11, 2:00 am through Saturday, September 12, 2:00 am (CEST), 2026
.If you encounter problems while ordering, please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Flow cytometric analysis of APC anti-human CD39 on peripheral blood. Human peripheral blood was stained simultaneously with FITC anti-human CD4 (clone RPA-T4, Cat. No. 5555346), PE-Cy7 anti-human CD25 (Clone M-A251, Cat. No. 557741), PE anti-human CD127 (clone hIL-7R-M21, Cat No. 557938) and APC anti-human CD39 (clone TU66) or an APC conjugated mouse IgG2b, κ isotype control (clone 27-35, Cat. No. 555745). Cells were then lysed and CD39 expression examined. CD39 expression is shown on regulatory T cells (solid line) versus isotype control (dotted line,left panel). RegulatoryT cells were identified from the gated events based on light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ cells shown as CD25bright,CD127dim population. (right panel). Flow cytometry was performed on a BD FACSCanto™ System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The TU66 monoclonal antibody specifically recognizes human CD39 which is also known as Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1), Ecto-ATP diphosphohydrolase 1 (Ecto-ATPDase 1), or Ecto-apyrase. CD39 is an integral membrane glycoprotein with two transmembrane domains, N- and C-terminal cytoplasmic tails, and an extracellular region that contains the NTPDase 1 active site. CD39 is encoded by ENTPD1 which belongs to the ectoenzyme family. CD39 is variably expressed on activated T cells and B cells, regulatory T cells (Treg), dendritic cells, Langerhans cells, NK cells, monocytes, macrophages, endothelial cells, and granulocytes. CD39 acts on extracellular nucleoside triphosphates and diphosphates including ATP and ADP that are hydrolyzed into AMP. Through cell surface CD73 (Ecto-5'-nucleotidase), regulatory T cells can act on extracellular AMP to generate immunosuppressive adenosine. CD39 is involved in the control of the extracellular pool of phosphorylated nucleosides, the suppression of inflammation and immunity, and the regulation of platelet activation.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.